Like most known ALS-linked molecules, it remains to be determined whether the functional consequences of CCNF mutations lead to a toxic gain of function or dominant-negative loss of function or haploinsufficiency. This evidence concerns the gene CCNF and amyotrophic lateral sclerosis.